Psychedelic drug abuse potential assessment for new drug applications and controlled substance scheduling: A United States perspective von Henningfield, Jack E., Ashworth, Judy, Heal, David J., Smith, Sharon L.

Volltext

Kratom Abuse Potential 2021: An Updated Eight Factor Analysis von Henningfield, Jack E, Wang, Daniel W, Huestis, Marilyn A

Volltext

Understanding Kratom Use: A Guide for Healthcare Providers von Swogger, Marc T, Smith, Kirsten E, Garcia-Romeu, Albert, Grundmann, Oliver, Veltri, Charles A, Henningfield, Jack E, Busch, Lorna Y

Volltext

Kratom safety and toxicology in the public health context: research needs to better inform regulation von Henningfield, Jack E, Grundmann, Oliver, Huestis, Marilyn A, Smith, Kirsten E

Volltext

A randomized, double-blind, placebo-controlled, crossover study to evaluate the human abuse liability of solriamfetol, a selective dopamine and norepinephrine reuptake inhibitor von Carter, Lawrence P, Henningfield, Jack E, Wang, Y Grace, Lu, Yuan, Kelsh, Debra, Vince, Bradley, Sellers, Edward

Volltext

The novel uncompetitive NMDA receptor antagonist esmethadone (REL-1017) has no meaningful abuse potential in recreational drug users von Shram, Megan J., Henningfield, Jack E., Apseloff, Glen, Gorodetzky, Charles W., De Martin, Sara, Vocci, Frank L., Sapienza, Frank L., Kosten, Thomas R., Huston, Jeff, Buchhalter, August, Ashworth, Judy, Lanier, Ryan, Folli, Franco, Mattarei, Andrea, Guidetti, Clotilde, Comai, Stefano, O’Gorman, Cedric, Traversa, Sergio, Inturrisi, Charles E., Manfredi, Paolo L., Pappagallo, Marco

Volltext

Psychedelics: Where we are now, why we got here, what we must do von Belouin, Sean J., Henningfield, Jack E.

Volltext

Evaluation of the abuse potential of difelikefalin, a selective kappa‐opioid receptor agonist, in recreational polydrug users von Shram, Megan J., Spencer, Robert H., Qian, Jenny, Munera, Catherine L., Lewis, Michael E., Henningfield, Jack E., Webster, Lynn, Menzaghi, Frédérique

Volltext

Advancing equity, diversity, and inclusion in the American College of Neuropsychopharmacology (ACNP): advances, challenges, and opportunities to accelerate progress von Henningfield, Jack E, Fields, Sherecce, Anthony, James C, Brown, Jr, Lawrence S, Bolaños-Guzmán, Carlos A, Comer, Sandra D, De La Garza, 2nd, Richard, Furr-Holden, Debra, Garcia-Romeu, Albert, Hatsukami, Dorothy K, Raznahan, Armin, Zarate, Carlos A

Volltext

The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act von Johnson, Matthew W., Griffiths, Roland R., Hendricks, Peter S., Henningfield, Jack E.

Volltext

Pain Management Strategies and Lessons from the Military: A Narrative Review von Vallerand, April Hazard, Cosler, Patricia, Henningfield, Jack E., Galassini, Pam

Volltext

Abuse Liability Assessment of Tobacco Products Including Potential Reduced Exposure Products von Carter, Lawrence P, Stitzer, Maxine L, Henningfield, Jack E, O'Connor, Rich J, Cummings, K Michael, Hatsukami, Dorothy K

Volltext

Reply to Drs. Hart and Cadet: we agree-the challenges of increasing equity, diversity and inclusion include societal issues and actions now are vital von Henningfield, Jack E, Fields, Sherecce, Anthony, James C, Brown, Jr, Lawrence S, Bolaños-Guzmán, Carlos A, Comer, Sandra D, De La Garza, 2nd, Richard, Furr-Holden, Debra, Garcia-Romeu, Albert, Hatsukami, Dorothy, Raznahan, Armin, Zarate, Jr, Carlos A

Volltext

The abuse potential of kratom according the 8 factors of the controlled substances act: implications for regulation and research von Henningfield, Jack E., Fant, Reginald V., Wang, Daniel W.

Volltext

Reducing the nicotine content to make cigarettes less addictive von Benowitz, Neal L, Henningfield, Jack E

Volltext

Kratom withdrawal: Discussions and conclusions of a scientific expert forum von Henningfield, Jack E., Chawarski, Marek C., Garcia-Romeu, Albert, Grundmann, Oliver, Harun, Norsyifa, Hassan, Zurina, McCurdy, Christopher R., McMahon, Lance R., Sharma, Abhisheak, Shoaib, Mohammed, Singh, Darshan, Smith, Kirsten E., Swogger, Marc T., Vicknasingam, Balasingam, Walsh, Zachary, Wang, Daniel W., Huestis, Marilyn A.

Volltext

The abuse potential of lemborexant, a dual orexin receptor antagonist, according to the 8 factors of the Controlled Substances Act von Moline, Margaret, Asakura, Shoji, Beuckman, Carsten, Landry, Ishani, Setnik, Beatrice, Ashworth, Judy, Henningfield, Jack E.

Volltext

Current and Future Potential Impact of COVID-19 on Kratom ( Mitragyna speciosa Korth.) Supply and Use von Singh, Darshan, Brown, Paula N, Cinosi, Eduardo, Corazza, Ornella, Henningfield, Jack E, Garcia-Romeu, Albert, McCurdy, Christopher R, McMahon, Lance R, Prozialeck, Walter C, Smith, Kirsten E, Swogger, Marc T, Veltri, Charles, Walsh, Zach, Grundmann, Oliver

Volltext

We Need Better Estimates of Kratom Use Prevalence von Henningfield, Jack E, Grundmann, Oliver, Garcia-Romeu, Albert, Swogger, Marc T

Volltext

The tobacco endgame: It's all about behavior von Henningfield, Jack E

Volltext